4.5 Interaction with other medicines and other forms of interaction Dulaglutide causes a delay in gastric emptying and thereby has …

Checking your browser before accessing pmc.ncbi.nlm.nih.gov ...

Dulaglutide chemical information summary. QA - Alimentary tract and metabolism QA10 - Drugs used in diabetes QA10B - Blood …

Trulicity is a once-weekly injectable prescription medicine to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It …

Learn about weight loss and BMI data for Trulicity (dulaglutide) at 1.5, 3.0, and 4.5 mg doses, based on clinical trial results.

Severe gastrointestinal disease Dulaglutide has not been studied in patients with severe gastrointestinal disease, including severe …

Dulaglutide could be considered for the management of glycaemic control in middle-aged and older people with type 2 diabetes with …

Sep 3, 2014 · Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes Krystal L Edwards,1 Molly G …

Dulaglutide is defined as a once-weekly GLP-1 receptor agonist, approved for the treatment of type 2 diabetes mellitus (T2DM), that …

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

Nov 8, 2024 · Dulaglutide Medication Information Discover comprehensive details about Dulaglutide, including its pronunciation, …

To compare efficacy and safety of dulaglutide at doses of 3.0 and 4.5 mg versus 1.5 mg in patients with type 2 diabetes inadequately …

Feb 24, 2026 · Easy-to-read patient tips for dulaglutide covering how it works, benefits, risks, and best practices.

Dulaglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist that augments glucose-dependent insulin secretion, and …